retatrutide phase 3 triumph Achieves Up to 30.3% Average Weight Loss in TRIUMPH-1 Trial ADA26: retatrutide delivers unprecedented weight

The legal proceedings have garnered attention not only for the nature of the claims but also for the nature of the claims but also for the innovative approach to selecting lead counsel, which could set a precedent for future large-scale litigations

Dehydration risk increases if nausea or vomiting occurs, making fluid intake monitoring critical

Early Weeks Most people begin noticing appetite changes within the first few weeks

In a separate study, subjects exhibited as much as a 26.1% reduction in total body fat mass post treatment

As consumer expectations evolve and new therapies emerge, providers must confront a challenging question: What happens if and when surgery is no longer the default standard of care

Ungvari Z et al